Epidemiology of leishmaniasis in Ecuador: current status of knowledge - A review
Open Access
- 1 November 2004
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 99 (7), 663-672
- https://doi.org/10.1590/s0074-02762004000700001
Abstract
Although leishmaniasis is regarded as a significant health problem in Ecuador by the Ministry of Health, and the incidence has increased over the last years, an official map on the geographic distribution of disease and sand fly vectors or a control strategy do not exist yet. This article reviews the current situation based on published information to improve our knowledge and understand the epidemiological situation of leishmaniasis in Ecuador in order to help future research and to develop a national control strategy. The disease is endemic in most provinces throughout Pacific coastal region, Amazonian lowlands, and some inter-Andean valleys with a total 21,805 cases reported during 1990-2003. Whereas cutaneous leishmaniasis (CL) is found throughout Ecuador, mucocutaneous leishmaniasis (MCL) appears to be restricted to the Amazon region; one, parasitologically unconfirmed case of visceral form was reported in 1949. Most human infections are caused by Leishmania (Viannia) spp., which is distributed in the subtropical and tropical lowlands; infections due to L. (Leishmania) spp. are found in the Andean highlands and in the Pacific lowlands as well. The proven vectors are Lutzomyia trapidoi and Lu. ayacuchensis. Canis familiaris, Sciurus vulgaris, Potos flavus, and Tamandua tetradactyla have been found infected with Leishmania spp. It is estimated that around 3000-4500 people may be infected every year, and that 3.1 to 4.5 millions people are estimated to be at risk of contracting leishmaniasis.Keywords
This publication has 48 references indexed in Scilit:
- Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasisActa Tropica, 2004
- Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasisVaccine, 2004
- Field Trial of a Vaccine against New World Cutaneous Leishmaniasis in an At‐Risk Child Population: How Long Does Protection Last?The Journal of Infectious Diseases, 2003
- Epidemiology of Chagas disease in Ecuador. A brief reviewMemórias do Instituto Oswaldo Cruz, 1999
- PCR detection and identification of Leishmania parasites in clinical specimens in Ecuador: a comparison with classical diagnostic methods.Journal of Parasitology, 1999
- Field Trial of a Vaccine against New World Cutaneous Leishmaniasis in an At‐Risk Child Population: Safety, Immunogenicity, and Efficacy during the First 12 Months of Follow‐UpThe Journal of Infectious Diseases, 1998
- Evidence for Hybridization by Multilocus Enzyme Electrophoresis and Random Amplified Polymorphic DNA Between Leishmania braziliensis and Leishmania panamensis/guyanensis in EcuadorThe Journal of Eukaryotic Microbiology, 1997
- The epidemiology of cutaneous leishmaniasis in subtropical EcuadorTropical Medicine & International Health, 1997
- New records of phlebotomine sand flies (Diptera: Psychodidae) from EcuadorMemórias do Instituto Oswaldo Cruz, 1992
- Human Cutaneous Leishmaniasis in Ecuador: Identification of Parasites by Enzyme ElectrophoresisThe American Journal of Tropical Medicine and Hygiene, 1990